TWST
Twist Bioscience Corp
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$166.99
+7.35%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.44
- Revenue estimate
- $123.6M
Latest reported
- Last report date
- Aug 3, 2026
- EPS actual
- -$0.56
- EPS estimate
- -$0.51
- Revenue actual
- $118.4M
- Revenue estimate
- $114.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -7.8%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $111
- PT range
- $45 – $160
- Analysts
- 9
6 Buy2 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 3, 2026 | -$0.51 | -$0.56 | Miss -10.62% | $118.4M |
| May 4, 2026 | -$0.49 | -$0.62 | Miss -26.53% | $110.7M |
| Feb 2, 2026 | -$0.48 | -$0.50 | Miss -4.17% | $103.7M |
| Nov 14, 2025 | -$0.50 | -$0.45 | Beat 10.00% | $99.0M |
| Feb 3, 2025 | -$0.62 | -$0.53 | Beat 14.52% | $88.7M |
| Nov 18, 2024 | -$0.71 | -$0.59 | Beat 17.35% | $84.7M |
| Aug 2, 2024 | -$0.79 | -$0.86 | Miss -8.86% | $81.5M |
| May 2, 2024 | -$0.84 | -$0.79 | Beat 5.95% | $75.3M |
| Feb 2, 2024 | -$0.80 | -$0.75 | Beat 6.25% | $71.5M |
| Nov 17, 2023 | -$0.94 | -$0.81 | Beat 13.83% | $66.9M |
| Aug 4, 2023 | -$1.14 | -$1.01 | Beat 11.40% | $63.7M |
| May 5, 2023 | -$1.09 | -$1.06 | Beat 2.75% | $60.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026